Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal

Journal of Neurology

Volumn 262, Issue 8, 2015, Pages 1946-1953

  Epprecht, L ^a   Schreglmann, S R ^a,b   Goetze, O ^c,e   Woitalla, D ^d   Baumann, C R ^b   Waldvogel, D ^b  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d ST JOSEF HOSPITAL   (Germany)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Appetite sensation; Dopaminergic treatment; Gastric emptying; High caloric test meal; Parkinson's disease

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; OCTANOIC ACID C 13; BENSERAZIDE; BENSERAZIDE, LEVODOPA DRUG COMBINATION; DRUG COMBINATION; OCTANOIC ACID; OCTANOIC ACID DERIVATIVE;

AGED; APPETITE; ARTICLE; BREATH ANALYSIS; CALORIC VESTIBULAR TEST; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DYSPEPSIA; FEMALE; GROUPS BY AGE; HOEHN AND YAHR SCALE; HUMAN; MALE; OCTANOATE BREATH TEST; OUTCOME ASSESSMENT; PARKINSON DISEASE; PERCEPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSATION; SINGLE BLIND PROCEDURE; STOMACH EMPTYING; STOMACH PARESIS; VISCERAL PERCEPTION; VISUAL ANALOG SCALE; ADULT; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECTS; MIDDLE AGED;

ADULT; AGED; APPETITE; BENSERAZIDE; BREATH TESTS; CAPRYLATES; DOPAMINE AGENTS; DRUG COMBINATIONS; GASTRIC EMPTYING; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES;

EID: 84939255537     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7799-z     Document Type: Article

References (48)

1. Adler CH (2005) Nonmotor complications in Parkinson’s disease. Mov Disord 1(20 Suppl 11):S23–S29
2. Gallagher DA, Lees AJ, Schrag A (2010) What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Mov Disord 25(15):2493–2500
3. Verbaan D, Marinus J, van Rooden SM, Stiggelbout AM, van Hilten JJ, Visser M (2007) Patient-reported autonomic symptoms in Parkinson disease. Neurology. 69(4):333–341
4. Antonini A, Barone P, Marconi R, Morgante L, Zappulla S, Pontieri FE et al (2012) The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life. J Neurol 259(12):2621–2631
5. Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol 2(2):107–116
6. Djaldetti R, Baron J, Ziv I, Melamed E (1996) Gastric emptying in Parkinson’s disease: patients with and without response fluctuations. Neurology 46(4):1051–1054
7. Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S et al (2001) Gastric emptying time and gastric motility in patients with Parkinson’s disease. Mov Disord 16(6):1041–1047
8. Goetze O, Wieczorek J, Mueller T, Przuntek H, Schmidt WE, Woitalla D (2005) Impaired gastric emptying of a solid test meal in patients with Parkinson’s disease using 13C-sodium octanoate breath test. Neurosci Lett 375(3):170–173
9. Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T et al (2010) Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson’s disease? An analysis using the 13C-acetate breath test. J Neurol 258(3):421–426
10. Tanaka Y, Kato T, Nishida H, Araki H, Murase M, Nagaki M et al (2009) Is there a difference in gastric emptying between Parkinson’s disease patients under long-term l-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test. J Neurol 256(12):1972–1976
11. Unger MM, Moeller JC, Mankel K, Schmittinger K, Eggert KM, Stamelou M et al (2011) Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the 13C-octanoate breath test. Mov Disord 26(14):2559–2563
12. Thomaides T, Karapanayiotides T, Zoukos Y, Haeropoulos C, Kerezoudi E, Demacopoulos N et al (2005) Gastric emptying after semi-solid food in multiple system atrophy and Parkinson disease. J Neurol 252(9):1055–1059
13. Abbott RA, Cox M, Markus H, Tomkins A (1992) Diet, body size and micronutrient status in Parkinson’s disease. Eur J Clin Nutr 46(12):879–884
14. Sharma JC, Vassallo M (2014) Prognostic significance of weight changes in Parkinson’s disease: the Park-weight phenotype. Neurodegener Dis Manag. 4(4):309–316
15. Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK (2013) Malnutrition in a sample of community-dwelling people with Parkinson’s disease. PLoS One 8(1):e53290
16. Robertson DR, Renwick AG, Wood ND, Cross N, Macklin BS, Fleming JS et al (1990) The influence of levodopa on gastric emptying in man. Br J Clin Pharmacol 29(1):47–53
17. Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ et al (1993) Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 104(6):1640–1647
18. Goetze O, Nikodem AB, Wiezcorek J, Banasch M, Przuntek H, Mueller T et al (2006) Predictors of gastric emptying in Parkinson’s disease. Neurogastroenterol Motil 18(5):369–375
19. Fraser A, Delaney B, Ford A, Qume M, Moayyedi P (2007) The short-form leeds dyspepsia questionnaire validation study. Aliment Pharmacol Ther 25(4):477–486
20. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ et al (2003) Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 18(1):141–150
21. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653
22. Robertson DR, Renwick AG, Macklin B, Jones S, Waller DG, George CF et al (1992) The influence of levodopa on gastric emptying in healthy elderly volunteers. Eur J Clin Pharmacol 42(4):409–412
23. Ziessman HA, Okolo PI, Mullin GE, Chander A (2009) Liquid gastric emptying is often abnormal when solid emptying is normal. J Clin Gastroenterol 43(7):639–643
24. Maes BD, Ghoos YF, Geypens BJ, Hiele MI, Rutgeerts PJ (1995) Relation between gastric emptying rate and energy intake in children compared with adults. Gut 36(2):183–188
25. Calbet JA, MacLean DA (1997) Role of caloric content on gastric emptying in humans. J Physiol 498(Pt 2):553–559
26. Peracchi M, Gebbia C, Ogliari C, Fraquelli M, Viganò R, Baldassarri A et al (2000) Influence of caloric intake on gastric emptying of solids assessed by 13C-octanoic acid breath test. Scand J Gastroenterol 35(8):814–818
27. Janssen P, Vanden Berghe P, Verschueren S, Lehmann A, Depoortere I, Tack J (2011) Review article: the role of gastric motility in the control of food intake. Aliment Pharmacol Ther 33(8):880–894
28. Hellström PM, Grybäck P, Jacobsson H (2006) The physiology of gastric emptying. Best Pract Res Clin Anaesthesiol 20(3):397–407
29. Unger MM, Möller JC, Mankel K, Eggert KM, Bohne K, Bodden M et al (2011) Postprandial ghrelin response is reduced in patients with Parkinson“s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson”s disease? J Neurol 258(6):982–990
30. Unger MM, Ekman R, Björklund A-K, Karlsson G, Andersson C, Mankel K et al (2013) Unimpaired postprandial pancreatic polypeptide secretion in Parkinson’s disease and REM sleep behavior disorder. Mov Disord 28(4):529–533
31. Rijkelijkhuizen JM, McQuarrie K, Girman CJ, Stein PP, Mari A, Holst JJ et al (2010) Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses. Metab Clin Exp 59(4):502–511
32. Vollmer K, Gardiwal H, Menge BA, Goetze O, Deacon CF, Schmidt WE et al (2009) Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans. J Clin Endocrinol Metab 94(4):1379–1385
33. Meier JJ, Gallwitz B, Salmen S, Goetze O, Holst JJ, Schmidt WE et al (2003) Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 88(6):2719–2725
34. Heetun ZS, Quigley EMM (2012) Gastroparesis and Parkinson´s disease: a systematic review. Parkinsonism Relat Disord. 18(5):433–440
35. Marrinan S, Emmanuel AV, Burn DJ (2013) Delayed gastric emptying in Parkinson’s disease. Mov Disord 29(1):23–32
36. Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach‘s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396(1):67–72
37. Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG (2012) Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol 124(5):665–680
38. Sheiner HJ, Quinlan MF, Thompson IJ (1980) Gastric motility and emptying in normal and post-vagotomy subjects. Gut 21(9):753–759
39. Begg DP, Woods SC (2013) The endocrinology of food intake. Nature Rev Endocrinol 9(10):584–597
40. Aiello M, Eleopra R, Rumiati RI (2014) Body weight and food intake in Parkinson’s disease. A review of the association to non-motor symptoms. Appetite 23(84C):204–211
41. Berkowitz DM, McCallum RW (1980) Interaction of levodopa and metoclopramide on gastric emptying. Clin Pharmacol Ther 27(3):414–420
42. Nagahata Y, Azumi Y, Kawakita N, Wada T, Saitoh Y (1995) Inhibitory effect of dopamine on gastric motility in rats. Scand J Gastroenterol 30(9):880–885
43. Wang L, Murphy NP, Stengel A, Goebel-Stengel M, St Pierre DH, Maidment NT et al (2012) Ghrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats. Neurogastroenterol Motil 24(5):e235–e245
44. Nyholm D, Lennernäs H (2008) Irregular gastrointestinal drug absorption in Parkinson’s disease. Expert Opin Drug Metab Toxicol 4(2):193–203
45. Kurlan R, Rothfield KP, Woodward WR, Nutt JG, Miller C, Lichter D et al (1988) Erratic gastric emptying of levodopa may cause “random” fluctuations of parkinsonian mobility. Neurology 38(3):419–421
46. Doi H, Sakakibara R, Sato M, Masaka T, Kishi M, Tateno A et al (2012) Plasma levodopa peak delay and impaired gastric emptying in Parkinson’s disease. J Neurol Sci 319(1–2):86–88
47. Müller T, Erdmann C, Bremen D, Schmidt WE, Muhlack S, Woitalla D et al (2006) Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients. Clin Neuropharmacol 29(2):61–67
48. Moss C, Dhillo WS, Frost G, Hickson M (2012) Gastrointestinal hormones: the regulation of appetite and the anorexia of ageing. J Hum Nutr Diet 25(1):3–15